Decreased and Phentermine


Decreased Symptoms and Causes

Complex regional pain syndrome (CRPS) is a chronic pain condition. It causes intense pain, usually in the arms, hands, legs, or feet. It may happen after an injury, either to a nerve or to tissue in the affected area. Rest and time may only make it worse.

Symptoms in the affected area are

  • Dramatic changes in skin temperature, color, or texture
  • Intense burning pain
  • Extreme skin sensitivity
  • Swelling and stiffness in affected joints
  • Decreased ability to move the affected body part

The cause of CRPS is unknown. There is no specific diagnostic test. Your doctor will diagnose CRPS based on your signs and symptoms.

There is no cure. It can get worse over time, and may spread to other parts of the body. Occasionally it goes away, either temporarily or for good. Treatment focuses on relieving the pain, and can include medicines, physical therapy, and nerve blocks.

NIH: National Institute of Neurological Disorders and Stroke

Check out the latest treatments for decreased

decreased treatment research studies

Phentermine clinical trials, surveys and public health registries

Find Drug Side Effect reports

Phentermine Side Effects

Pain (28)
Dyspnoea (27)
Anxiety (26)
Chest Pain (22)
Deep Vein Thrombosis (20)
Nausea (19)
Abdominal Pain (18)
Headache (16)
Blood Pressure Increased (16)
Abdominal Pain Upper (16)
Mitral Valve Incompetence (15)
Cholelithiasis (15)
Cholecystitis Chronic (14)
Pulmonary Embolism (14)
Injury (13)
Vomiting (13)
Ventricular Fibrillation (13)
Myocardial Infarction (13)
Loss Of Consciousness (12)
Dizziness (12)
Colitis Ischaemic (11)
Cardiac Arrest (11)
Gallbladder Disorder (10)
Fatigue (10)
Insomnia (10)
Cerebrovascular Accident (9)
Hypertension (9)
Arteriospasm Coronary (9)
Palpitations (8)
Confusional State (8)
Chest Discomfort (7)
Convulsion (7)
Hypotension (7)
Emotional Distress (7)
Feeling Abnormal (7)
Asthenia (6)
Abnormal Behaviour (6)
Diarrhoea (6)
Pain In Extremity (6)
Hypoaesthesia (6)
Tricuspid Valve Incompetence (6)
Hypercoagulation (5)
Alanine Aminotransferase Increased (5)
Mental Disorder (5)
Heart Rate Increased (5)
Pneumomediastinum (5)
Ventricular Tachycardia (5)
Respiratory Arrest (5)
Pyrexia (5)
Migraine (5)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

1st day was hell, had about every side effect in the book. 2nd day was better, side effects decreased greatly 5th day is going well so far- feeling a little 'edgy & apprehensive' but better than the alternative

After a few weeks on Piascledine, knee and back pain decreased considerably with no side effects noted. Not perfect, but much better. I was walking like an old man.

An addition to Frances Wedderburn's side effects from Januvia, some of my Liver Enzymes became elevated. They decreased when checked 10 days after stopping Januvia. Diarrhoea continues

Been taking Omnic or about 2months and have experienced decreased semen production. Is this a common side effect of taking Omnic or a new symptom of a slightly enlarged prostate? Thanks

Can Moxonidine be given to patients with Hypertensive bleed who already has decreased conciousness levels.(GCS of E2 M5 V2)

Day 1: Smoked as per usual, VERY difficult to fall asleep d/t pruritis, RLS, as well as geralized restlessness Day 2 : Smoking decreased by half. Did not get much pleasure from it...nor anything else. Felt like a complete zombie,

Does anbody else experience sexual dysfunction side effects with Zeldox? I do hame side effects including flatulence, decreased mental alertness, drowsiness, even a bit of stupour sometimes too.

Female 125 lbs 59 years old. taking hydroxyureas for 1 month - only half the dose prescribed - hair thinnning, some fatigue, and digestive problems. Platelet count decreased by 200,000 but not enough to get it under 1 million. Not happy about taki

Hi was wondering if anyone had rapid weight gain on the champix? I've gone from a size 6 to a size 10 in just 5 days and my appatite has decreased so it's not from food, I do have a marina IUD so does anyone know if the champix and IUD are causing w

Hi, I am a medical student and I have a question. I had a patient today with RTA, for which she has been taking Bicitra for 3.5 years. Her PMD recently decreased her dosage because of hyercalcemia. Has Bicitra been known to cause hypercalemia? Th

Decreased Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Nurse Reduction of Pulled Elbow
Condition: Radial Head Subluxation
Intervention: Procedure: Reduction of Radial Head Subluxation
Outcome Measures: Proportion of patients with successful reduction of radial head subluxation by nurse, compared with physician controls;   Time to normal usage (minutes);   Time to discharge from ED (minutes);   Proportion of patients with presentation compatible with RHS, have reduction attempted, who are subsequently diagnosed with fracture.;   Proportion of patients with RHS not identified by nurse pathway.
2 Not yet recruiting Project 2: Strategies for Reducing Nicotine Content in Cigarettes
Conditions: Immediate Nicotine Reduction Group;   Gradual Nicotine Reduction Group;   Normal Nicotine Control Group
Intervention: Behavioral: Smoking Spectrum Brand Cigarettes for 20 weeks.
Outcome Measures: Toxicant exposure pattern;   Cigarettes per day;   Nicotine exposure;   Other toxicant exposure;   Effect biomarker;   Cessation rates;   Measure of acceptability;   Measure of acceptability: Non-compliance
3 Recruiting A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation
Condition: Nicotine Addiction
Interventions: Other: Scheduled Gradual Reduction + Varenicline;   Other: Scheduled Gradual Reduction + Placebo Drug;   Other: Basic Advice + Varenicline;   Other: Basic Advice + Placebo Drug
Outcome Measures: Comparison of Prolonged Abstinence;   Comparison of Continuous Abstinence;   Comparison of Survival
4 Unknown  Behavioral Activation and HIV Risk Reduction for Men Who Have Sex With Men With Crystal Meth Abuse
Conditions: Crystal Methamphetamine Abuse;   Crystal Methamphetamine Dependence
Interventions: Behavioral: Behavioral Activation Therapy and Risk Reduction Counseling (BAT-RR);   Behavioral: Information, Motivation, Behavioral skills change approach to sexual risk reduction
Outcome Measures: Change in sexual risk;   Change in crystal methamphetamine use
5 Recruiting Volar Internal Plate Fixation vs. Plaster in Extra- Articular Distal Radial Fractures
Condition: Displaced Extra-articular Distal Radius Fractures
Interventions: Procedure: open reduction and internal fixation;   Other: Closed reduction and plaster
Outcome Measures: Wrist function/pain/disability at one year assessed with DASH score and PRWE score;   Quality of Life;   Pain;   Patient satisfaction;   Range of motion;   Grip strength;   Radiological parameters;   Complications
6 Recruiting Behavioral Drug and HIV Risk Reduction Counseling With MMT in China
Condition: Opiate Dependence
Interventions: Behavioral: Behavioral Drug and HIV Risk Reduction Counseling;   Behavioral: Educational Counseling;   Behavioral: Treatment as Usual
Outcome Measures: Reduction of drug- and sex-related HIV risk behaviors;   Reduction of frequency (days of illicit opiate use in each month) of heroin or other illicit opiate use;   Treatment retention;   Reductions in other illicit drug use;   Improvements of functional status (e.g., in vocational, family, and social functioning, and healthcare and other resource utilization)
7 Unknown  The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy
Condition: Intractable Epilepsy
Interventions: Other: Reduction of anti-epileptic medications;   Procedure: No drug change
Outcome Measures: Effect of reduction in anti-epileptic medications on quality of life in young people with intractable epilepsy;   Identify other determinants of quality of life in this group of subjects
8 Recruiting BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit
Conditions: Smoking;   Pregnancy
Interventions: Behavioral: Scheduled Gradual Reduction Text Messages;   Behavioral: Support Text Messages
Outcome Measures: biochemically validated seven-day point prevalence smoking abstinence;   prolonged smoking abstinence;   biochemically validated smoking reduction;   biochemically validated postpartum smoking abstinence;   preterm birth
9 Recruiting Reduced Calorie Diet Intervention in Kidney Transplant Recipients
Condition: Chronic Kidney Disease
Intervention: Other: reduced calorie diet
Outcome Measures: a significant improvement in measures of body composition (including weight, BMI, and fat mass);   an improvement in insulin resistance;   a decrease in oxidative stress markers;   an improvement in kidney function
10 Recruiting Ablation and Left Atrium Reduction During Mitral Valve Surgery for Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: maze procedure;   Procedure: mitral valve surgery;   Procedure: left atrial reduction
Outcome Measures: Freedom from atrial fibrillation;   Rate of significant adverse events
11 Not yet recruiting China Salt Substitute and Stroke Study
Condition: Stroke
Intervention: Behavioral: Dietary sodium reduction
Outcome Measures: Stroke;   Total major vascular events;   Total mortality
12 Recruiting Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders
Conditions: Non Malignant Diseases;   Immunodeficiencies;   Hemoglobinopathies
Intervention: Other: Hematopoetic Stem Cell Transplant using Reduced Intensity Conditioning Regimen
Outcome Measure: Engraftment and Survival
13 Unknown  Ultrasound Assisted Distal Radius Fracture Reduction
Conditions: Colles Fracture;   Point of Care Ultrasound;   Emergency Ultrasound
Intervention: Device: Point of care ultrasound
Outcome Measures: Efficacy of Point of care ultrasound in Identifying colles fracture reduction;   Number of reduction attempts affected by ultrasound;   Time to imaging
14 Recruiting Calcineurin-inhibitor Elimination/Reduction Randomized to Everolimus/Myfortic® vs Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction
Condition: Renal Transplant
Interventions: Drug: Arm 1 Everolimus/myfortic®;   Drug: Arm 2 Everolimus/Reduced dose tacrolimus
Outcome Measures: Renal function;   Graft survival;   Biopsy proven acute rejection;   Patient survival;   Impaired glucose tolerance;   Proteinuria;   Lipid levels;   Mouth ulcers;   Gastrointestinal complaints;   Leukopenia;   Thrombocytopenia;   Neurotoxicity;   Pneumonitis;   Cytomegalovirus;   Infection requiring hospitalization;   BK infection;   BK nephropathy;   Malignancies;   Cardiovascular complications;   Development of donor specific antibody
15 Recruiting Peer Leaders as HIV Risk Reduction Change Agents Among Injection Drug Users (IDUs) in Ukraine
Conditions: HIV Infections;   Intervention
Interventions: Behavioral: Peer Education Model;   Behavioral: HIV Counseling and Education Model
Outcome Measures: HIV Knowledge;   Self-efficacy regarding HIV risk reduction;   Injection risk behavior reduction;   Sex-related risk behavior reduction;   Intervention diffusion to secondary network members
16 Recruiting Low Cost Biological Lung Volume Reduction Therapy for Advanced Emphysema
Condition: Advanced Pulmonary Emphysema
Intervention: Procedure: Bronchoscopic Lung volume reduction
Outcome Measures: Post-procedure lung volume reduction;   Post-procedure Improvement in dyspnea and exercise capacity
17 Not yet recruiting Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders
Condition: Tobacco Dependence
Interventions: Drug: Reduced Nicotine Content Cigarettes;   Drug: Usual Nicotine Content Cigarettes
Outcome Measures: Plasma Cotinine Concentration;   Ratings of psychiatric and nicotine withdrawal symptoms
18 Recruiting Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process
Condition: Aplasia With Expected Thrombocytopenia
Interventions: Biological: Autologous plasma;   Biological: Additive solution;   Biological: Pathogen reduction process
Outcome Measures: Incidence of grade 2 or higher (WHO) haemorrhagic episodes;   Frequency incidence of haemorrhagic episodes (grade 1 and higher);   Number of serious grade 3-4 haemorrhagic episodes;   Number of minor grade 1 haemorrhagic episodes;   Transfusion outcome in platelets (CCI) at 24 hours;   Number of transfusions of platelet concentrates and red blood cells;   Transfusion intervals;   Safety (transfusion side effects) grade 2 or higher;   Occurrence of anti-platelet antibodies (Anti-HLA, anti-HPA);   Occurrence of platelet transfusions refractiveness;   Validation of a new haemorrhagic evaluation: EFS scale;   Variation in hematocrit and hemoglobin levels
19 Unknown  Effectiveness Study of the UltraShape® Contour I-Y for Non-Invasive Reduction in Abdominal Circumference
Condition: Reduction in Abdominal Circumference
Intervention: Device: Treatment with Contour I-Y system
Outcome Measures: The primary objective of this study is to evaluate the efficacy of the Contour I - Y System on abdominal circumference reduction relative to baseline pretreatment values using different treatment methods.;   The secondary objective of this study subject satisfaction measured with a self-assessment questionnaire;   Rate of device and procedure related adverse event adverse
20 Recruiting Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine
Conditions: Nicotine Addiction;   Panic Attack
Interventions: Drug: d-cycloserine;   Drug: Pill Placebo;   Drug: Nicotine replacement therapy;   Behavioral: Panic and Smoking Reduction Treatment
Outcome Measure: Smoking Status